Verducatib is an investigational new drug that is being evaluated by Boehringer Ingelheim for the treatment of bronchiectasis. It is a cathepsin C inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.